Trial Outcomes & Findings for Patient-Centered Support for Contraceptive Decision-Making (NCT NCT02078713)
NCT ID: NCT02078713
Last Updated: 2018-11-19
Results Overview
Whether or not a participant is still using the contraceptive method she selected at baseline.
COMPLETED
NA
786 participants
4 and 7 months post-enrollment
2018-11-19
Participant Flow
Female patients were approached to participate in the study before appointments at four San Francisco Bay Area clinics between December 2014 and March 2016. Patients are grouped in cluster by provider. Providers of family planning care at the four clinics were approached to participate in the study in October to December 2014.
A total of 2,458 patients were approached to participate in the study. Of these, 1,700 were excluded before assignment (1,642 due to ineligibility, 58 refusals), and 758 enrolled. A total of 36 providers were approached to participate. Eight were excluded before assignment (7 due to ineligibility, 1 refusal), and 28 enrolled.
Participant milestones
| Measure |
Contraceptive Decision Support Tool Patients
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control) Patients
Patients in this arm will receive usual family planning care.
|
Contraceptive Decision Support Tool Providers
Family planning providers randomized to use the Contraceptive Decision Support tool with their patients in the study.
|
Usual Care (Control) Providers
Family planning providers randomized to deliver usual care to their patient in the study.
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
407
|
351
|
15
|
13
|
|
Overall Study
COMPLETED
|
355
|
290
|
15
|
13
|
|
Overall Study
NOT COMPLETED
|
52
|
61
|
0
|
0
|
Reasons for withdrawal
| Measure |
Contraceptive Decision Support Tool Patients
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control) Patients
Patients in this arm will receive usual family planning care.
|
Contraceptive Decision Support Tool Providers
Family planning providers randomized to use the Contraceptive Decision Support tool with their patients in the study.
|
Usual Care (Control) Providers
Family planning providers randomized to deliver usual care to their patient in the study.
|
|---|---|---|---|---|
|
Overall Study
Lost to Follow-up
|
49
|
55
|
0
|
0
|
|
Overall Study
Pregnant at baseline
|
3
|
5
|
0
|
0
|
|
Overall Study
Enrolled twice
|
0
|
1
|
0
|
0
|
Baseline Characteristics
Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
Baseline characteristics by cohort
| Measure |
Contraceptive Decision Support Tool Patients
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control) Patients
n=345 Participants
Patients in this arm will receive usual family planning care.
|
Contraception Decision Support Tool Providers
n=15 Participants
Family planning providers randomized to use the Contraceptive Decision Support tool with their patients. Providers were the unit of randomization in this cluster trial
|
Usual Care (Control) Providers
n=13 Participants
Family planning providers randomized to practice usual care with their patients. Providers were the unit of randomization in this cluster trial
|
Total
n=777 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|
|
Age, Customized
Age category · 15-19
|
52 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
43 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
95 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Age, Customized
Age category · 20-24
|
126 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
121 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
2 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
1 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
250 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Age, Customized
Age category · 25-29
|
110 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
91 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
2 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
3 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
206 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Age, Customized
Age category · 30-34
|
68 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
53 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
1 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
3 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
125 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Age, Customized
Age category · 35-39
|
33 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
22 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
2 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
1 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
58 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Age, Customized
Age category · 40-45
|
13 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
10 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
4 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
1 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
28 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Age, Customized
Age category · Over 45
|
0 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
4 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
4 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
8 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Age, Customized
Age category · Missing
|
2 Participants
n=404 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
5 Participants
n=345 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=15 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=13 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
7 Participants
n=777 Participants • Patients were excluded if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Sex: Female, Male
Female
|
404 Participants
n=404 Participants
|
345 Participants
n=345 Participants
|
15 Participants
n=15 Participants
|
12 Participants
n=13 Participants
|
776 Participants
n=777 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=404 Participants
|
0 Participants
n=345 Participants
|
0 Participants
n=15 Participants
|
1 Participants
n=13 Participants
|
1 Participants
n=777 Participants
|
|
Race/Ethnicity, Customized
Race/ethnicity · African American/Black
|
46 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
34 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
80 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Race/Ethnicity, Customized
Race/ethnicity · Asian or Pacific Islander
|
59 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
62 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
2 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
123 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Race/Ethnicity, Customized
Race/ethnicity · Hispanic/Latina
|
160 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
128 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
4 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
4 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
296 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Race/Ethnicity, Customized
Race/ethnicity · White
|
86 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
85 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
8 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
9 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
188 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Race/Ethnicity, Customized
Race/ethnicity · Other
|
51 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
32 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
1 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
84 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Race/Ethnicity, Customized
Race/ethnicity · Missing
|
2 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
4 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
6 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Language spoken during study participation
English
|
329 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
283 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
15 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
13 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
640 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Language spoken during study participation
Spanish
|
75 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
62 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=15 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
0 Participants
n=13 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
137 Participants
n=777 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1).
|
|
Parental education
8th grade or less
|
69 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
50 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
119 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
|
Parental education
Some high school, but did not graduate
|
38 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
29 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
67 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
|
Parental education
High school graduate or GED
|
81 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
69 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
150 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
|
Parental education
Some college or 2-year degree
|
83 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
58 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
141 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
|
Parental education
4-year college graduate or more
|
129 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
133 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
262 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
|
Parental education
Missing
|
4 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
6 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
10 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
|
% Federal Poverty Line
<100%
|
183 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
141 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
324 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
|
% Federal Poverty Line
101-200%
|
81 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
79 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
160 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
|
% Federal Poverty Line
>200%
|
76 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
65 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
141 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
|
% Federal Poverty Line
Missing
|
64 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
60 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
124 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
|
Parity
Nulliparous
|
265 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
236 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
501 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
|
Parity
Parous
|
133 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
104 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
237 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
|
Parity
Missing
|
6 Participants
n=404 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
5 Participants
n=345 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
0 Participants
Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
11 Participants
n=749 Participants • Patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1). These data were not collected from the provider sample.
|
PRIMARY outcome
Timeframe: 4 and 7 months post-enrollmentPopulation: Analysis was modified intention to treat. In accordance with the statistical analysis plan, patients were excluded from analysis if they were pregnant at baseline (n=8) or enrolled in the study twice (n=1, in which case information from their second enrollment was excluded). Outcome observed in patients only.
Whether or not a participant is still using the contraceptive method she selected at baseline.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Contraceptive Continuation
7 months post-enrollment · Missing
|
49 Participants
|
53 Participants
|
|
Contraceptive Continuation
4 months post-enrollment · Continuous user of chosen method
|
249 Participants
|
228 Participants
|
|
Contraceptive Continuation
4 months post-enrollment · Not a continuous user of chosen method
|
115 Participants
|
83 Participants
|
|
Contraceptive Continuation
7 months post-enrollment · Continuous user of chosen method
|
201 Participants
|
174 Participants
|
|
Contraceptive Continuation
7 months post-enrollment · Not a continuous user of chosen method
|
154 Participants
|
118 Participants
|
|
Contraceptive Continuation
4 months post-enrollment · Missing
|
40 Participants
|
34 Participants
|
SECONDARY outcome
Timeframe: Baseline, post-visit surveyPopulation: Observed in patients only
Patient-reported score on an 11-item factor analysis-validated measure created by the PI to assess patients' satisfaction with the contraceptive counseling experience. The measure consists of 5-point Likert scale items on which patients evaluate provider performance, with item response options ranging from 1 ("Poor") to 5 ("Excellent"). The score range for the total measure is11-55, with 11 as the worst possible score and 55 as the best possible score for provider performance. Analyzed dichotomously, top score (55) versus all lower scores.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Patient Contraceptive Counseling Satisfaction
Top score of 55
|
261 Participants
|
194 Participants
|
|
Patient Contraceptive Counseling Satisfaction
Less than top score of 55
|
133 Participants
|
143 Participants
|
|
Patient Contraceptive Counseling Satisfaction
Missing
|
10 Participants
|
8 Participants
|
SECONDARY outcome
Timeframe: Baseline (post-visit survey)Population: Observed in patients only
Patient response to a 5-point Likert scale item about satisfaction with information that their provider gave them about side effects of their chosen methods during their baseline visit (1=completely unsatisfied, 5=completely satisfied). Analyzed dichotomously as top score of 5 versus \<5.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Patient Satisfaction With Information Received About Side Effects During Counseling
Top score of 5, completely satisfied
|
325 Participants
|
253 Participants
|
|
Patient Satisfaction With Information Received About Side Effects During Counseling
Less than 5
|
64 Participants
|
81 Participants
|
|
Patient Satisfaction With Information Received About Side Effects During Counseling
Missing
|
15 Participants
|
11 Participants
|
SECONDARY outcome
Timeframe: Baseline (post-visit survey)Population: Observed in patients only
Patient report on 5-point Likert scale of satisfaction with baseline visit (1=completely unsatisfied, 5=completely satisfied). Analyzed dichotomously as top score of 5 versus \<5.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Overall Satisfaction With Visit
Completely satisfied
|
338 Participants
|
282 Participants
|
|
Overall Satisfaction With Visit
Missing
|
10 Participants
|
9 Participants
|
|
Overall Satisfaction With Visit
Less than completely satisfied
|
56 Participants
|
54 Participants
|
SECONDARY outcome
Timeframe: Baseline (post-visit) and up to 24 monthsPopulation: Observed in patients only
Patient report on 3-point scale of their feelings about provider involvement in contraceptive decision-making: I wish provider had been less involved, provider was involved the right amount, I wiss provider had been more involved.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Shared Decision Making - Feelings About Provider Involvement
Right amount
|
370 Participants
|
305 Participants
|
|
Shared Decision Making - Feelings About Provider Involvement
Wish provider had been less involved
|
8 Participants
|
10 Participants
|
|
Shared Decision Making - Feelings About Provider Involvement
Wish provider had been more involved
|
16 Participants
|
21 Participants
|
|
Shared Decision Making - Feelings About Provider Involvement
Missing
|
10 Participants
|
9 Participants
|
SECONDARY outcome
Timeframe: Baseline (post-visit survey)Population: Observed in patients only
Patient report of attitude on 3-point scale on how provider expressed preference for contraceptive method choice: Right amount, wish less strongly, wish more strongly.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Shared Decision Making - Provider Appropriately Expressed Preference
No, I wish less
|
16 Participants
|
13 Participants
|
|
Shared Decision Making - Provider Appropriately Expressed Preference
Yes, exactly right
|
357 Participants
|
297 Participants
|
|
Shared Decision Making - Provider Appropriately Expressed Preference
No, I wish more
|
21 Participants
|
26 Participants
|
|
Shared Decision Making - Provider Appropriately Expressed Preference
Missing
|
10 Participants
|
9 Participants
|
SECONDARY outcome
Timeframe: Baseline (post-visit survey)Population: Observed in patients only
Patient report of satisfaction on a 5-point Likert scale (from 1=completely unsatisfied to 5=completely satisfied) of how the provider helped contraceptive method choice. Analyzed dichotomously as top score of 5 versus \<5.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Shared Decision Making - Satisfaction With How Provider Helped With Choice
Completely satisfied
|
303 Participants
|
240 Participants
|
|
Shared Decision Making - Satisfaction With How Provider Helped With Choice
Less than completely satisfied
|
91 Participants
|
96 Participants
|
|
Shared Decision Making - Satisfaction With How Provider Helped With Choice
Missing
|
10 Participants
|
9 Participants
|
SECONDARY outcome
Timeframe: Baseline (post-visit)Population: Observed in patients only
Patient response to 5-point scale of who made decision on contraceptive method. The original 5 points were the provider by themselves, more provider, both equally, more patient, or provider by themselves. In analysis, these options were collapsed to three points: more provider, both equally, or more patient.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Shared Decision Making - Who Made the Decision?
Patient
|
286 Participants
|
244 Participants
|
|
Shared Decision Making - Who Made the Decision?
Provider
|
20 Participants
|
9 Participants
|
|
Shared Decision Making - Who Made the Decision?
Both
|
88 Participants
|
83 Participants
|
|
Shared Decision Making - Who Made the Decision?
Missing
|
10 Participants
|
9 Participants
|
SECONDARY outcome
Timeframe: Baseline (post-visit survey)Population: Observed in patients only
Patient report of whether or not provider had preference for contraceptive method choice, reported on a 5-point scale: no preference, slight preference, moderate preference, strong preference, extremely strong preference. Analyzed dichotomously as any preference versus no preference.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Shared Decision Making - Provider Preference
Provider had preference
|
194 Participants
|
143 Participants
|
|
Shared Decision Making - Provider Preference
Provider had no preference
|
200 Participants
|
193 Participants
|
|
Shared Decision Making - Provider Preference
Missing
|
10 Participants
|
9 Participants
|
SECONDARY outcome
Timeframe: Baseline (post-visit)Population: Observed in patients only
Patient Decisional Conflict was measured using the Decisional Conflict Scale (DCS), a validated measure to assess patients' decisional conflict in medical decision making. The DCS includes 16 items about experience of conflict, with 5-point Likert response options ranging from 0 ("Strongly disagree") to 4 ("Strongly agree"). Higher scores indicate less conflict. Top score on DCS (Range: 0-100, analyzed dichotomously as 100 versus \<100). Top scores on subscales also analyzed (Informed decision, Uncertainty, Effective decision, Values clarity, Support, all ranging 0-100 and analyzed dichotomously as 100 versus \<100).
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Patient Decisional Conflict in Contraceptive Choice
Overall score · Top score
|
100 Participants
|
76 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Overall score · Less than top score
|
294 Participants
|
260 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Overall score · Missing
|
10 Participants
|
9 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Informed decision subscale · Top score
|
199 Participants
|
145 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Informed decision subscale · Less than top score
|
195 Participants
|
191 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Informed decision subscale · Missing
|
10 Participants
|
9 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Uncertainty subscale · Top score
|
164 Participants
|
112 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Uncertainty subscale · Less than top score
|
230 Participants
|
224 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Values clarity subscale · Less than top score
|
198 Participants
|
182 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Support subscale · Top score
|
207 Participants
|
172 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Support subscale · Less than top score
|
187 Participants
|
164 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Support subscale · Missing
|
10 Participants
|
9 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Uncertainty subscale · Missing
|
10 Participants
|
9 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Effective decision subscale · Top score
|
166 Participants
|
132 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Effective decision subscale · Less than top score
|
228 Participants
|
204 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Effective decision subscale · Missing
|
10 Participants
|
9 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Values clarity subscale · Top score
|
196 Participants
|
154 Participants
|
|
Patient Decisional Conflict in Contraceptive Choice
Values clarity subscale · Missing
|
10 Participants
|
9 Participants
|
SECONDARY outcome
Timeframe: Baseline (post-visit)Population: Observed in patients only
Patient responses to items derived from National Survey of Reproductive Contraceptive Knowledge and previous studies of contraceptive knowledge and attitudes. All items analyzed as correct vs. incorrect.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Patient Knowledge of Contraceptive Options and Features
IUDs are more effective than pills · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Depo is more effective than condoms · Correct
|
238 Participants
|
156 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Pills are more effective than condoms · Correct
|
220 Participants
|
170 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Pills are more effective than condoms · Incorrect
|
174 Participants
|
166 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Pills are more effective than condoms · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
IUDs are more effective than pills · Correct
|
279 Participants
|
162 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Methods causing periods to stop are safe · Correct
|
305 Participants
|
220 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Methods causing periods to stop are safe · Incorrect
|
89 Participants
|
116 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Depo is more effective than condoms · Incorrect
|
156 Participants
|
180 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Methods causing periods to stop are safe · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Depo does affect fertility · Incorrect
|
295 Participants
|
250 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Depo does affect fertility · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Hormonal IUD does not affect fertility · Correct
|
238 Participants
|
165 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Composite IUD knowledge · Correct
|
146 Participants
|
66 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Depo is more effective than condoms · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
IUDs are an option for nulliparous young women · Correct
|
315 Participants
|
228 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
IUDs are an option for nulliparous young women · Incorrect
|
79 Participants
|
108 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
IUDs are an option for nulliparous young women · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
IUDs are more effective than pills · Incorrect
|
115 Participants
|
174 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
LARC can be removed early · Correct
|
261 Participants
|
211 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
LARC can be removed early · Incorrect
|
133 Participants
|
125 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
LARC can be removed early · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Copper IUDs can act as EC · Correct
|
89 Participants
|
33 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Copper IUDs can act as EC · Incorrect
|
315 Participants
|
311 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Copper IUDs can act as EC · Missing
|
0 Participants
|
1 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
After sex, something to prevent pregnancy · Correct
|
371 Participants
|
320 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
After sex, something to prevent pregnancy · Incorrect
|
23 Participants
|
16 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
After sex, something to prevent pregnancy · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
EC can prevent pregnancy after sex · Correct
|
361 Participants
|
315 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
EC can prevent pregnancy after sex · Incorrect
|
43 Participants
|
29 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
EC can prevent pregnancy after sex · Missing
|
0 Participants
|
1 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Pill does not affect fertility · Correct
|
280 Participants
|
219 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Pill does not affect fertility · Incorrect
|
114 Participants
|
117 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Pill does not affect fertility · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Patch does not affect fertility · Correct
|
277 Participants
|
201 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Patch does not affect fertility · Incorrect
|
117 Participants
|
135 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Patch does not affect fertility · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Ring does not affect fertility · Correct
|
270 Participants
|
192 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Ring does not affect fertility · Incorrect
|
124 Participants
|
144 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Ring does not affect fertility · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Depo does affect fertility · Correct
|
99 Participants
|
86 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Hormonal IUD does not affect fertility · Incorrect
|
156 Participants
|
171 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Hormonal IUD does not affect fertility · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Non-hormonal IUD does not affect fertility · Correct
|
247 Participants
|
176 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Non-hormonal IUD does not affect fertility · Incorrect
|
147 Participants
|
160 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Non-hormonal IUD does not affect fertility · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Implant does not affect fertility · Correct
|
233 Participants
|
164 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Implant does not affect fertility · Incorrect
|
161 Participants
|
172 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Implant does not affect fertility · Missing
|
10 Participants
|
9 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Composite IUD knowledge · Incorrect
|
258 Participants
|
279 Participants
|
|
Patient Knowledge of Contraceptive Options and Features
Composite IUD knowledge · Missing
|
0 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: Reported and analyzed at baseline (post-visit), 4 months and 7 months follow-up5-point Likert scale item regarding patient satisfaction with contraceptive method chosen at baseline visit. The item is a statement of method satisfaction, and response options range from 1 ("Completely disagree") to 5 ("Completely agree"). A higher score indicates higher satisfaction. Analyzed dichotomously as top score (5) versus all lower scores.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Patient Chosen Contraceptive Method Satisfaction
4 months post-enrollment · Top score of 5
|
176 Participants
|
157 Participants
|
|
Patient Chosen Contraceptive Method Satisfaction
4 months post-enrollment · Less than top score
|
183 Participants
|
148 Participants
|
|
Patient Chosen Contraceptive Method Satisfaction
4 months post-enrollment · Missing
|
45 Participants
|
40 Participants
|
|
Patient Chosen Contraceptive Method Satisfaction
7 months post-enrollment · Missing
|
47 Participants
|
55 Participants
|
|
Patient Chosen Contraceptive Method Satisfaction
Baseline · Top score of 5
|
249 Participants
|
199 Participants
|
|
Patient Chosen Contraceptive Method Satisfaction
Baseline · Less than top score
|
145 Participants
|
137 Participants
|
|
Patient Chosen Contraceptive Method Satisfaction
Baseline · Missing
|
10 Participants
|
9 Participants
|
|
Patient Chosen Contraceptive Method Satisfaction
7 months post-enrollment · Top score of 5
|
180 Participants
|
160 Participants
|
|
Patient Chosen Contraceptive Method Satisfaction
7 months post-enrollment · Less than top score
|
177 Participants
|
130 Participants
|
SECONDARY outcome
Timeframe: 7 months follow-upPopulation: Observed in patients only
5-point Likert scale question regarding patient satisfaction with the contraceptive method they are currently using. The item is a statement of method satisfaction, and response options range from 1 ("Completely disagree") to 5 ("Completely agree"). A higher score indicates higher satisfaction. Analyzed dichotomously as top score of 5 versus \<5.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Patient Current Contraceptive Method Satisfaction
Missing
|
48 Participants
|
55 Participants
|
|
Patient Current Contraceptive Method Satisfaction
Completely satisfied
|
209 Participants
|
177 Participants
|
|
Patient Current Contraceptive Method Satisfaction
Less than completely satisfied
|
147 Participants
|
113 Participants
|
SECONDARY outcome
Timeframe: Baseline (post-visit survey)Population: Observed in patients only.
Patient ratings of contraceptive methods on the 11-point Global Contraceptive Attitude scale, developed by the PI. To assess overall (or "global") attitude towards use of various methods, patients are asked to respond the following with regard to each method listed in the data table: "Overall, how would you rate each of the following as a birth control method for yourself, (even if you've never used it)?" Response options range from 0 ("Terrible method") to 10 ("Great method"). A higher score on an individual item indicates a more positive attitude towards a method. Analyzed as discrete items with responses of 0 to 10; item scores not combined into an overall scale score.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Patient Attitude Towards Use of Contraceptive Options
Pill
|
6.26 Units on a scale
Standard Error 0.24
|
6.55 Units on a scale
Standard Error .289
|
|
Patient Attitude Towards Use of Contraceptive Options
Withdrawal
|
2.8 Units on a scale
Standard Error 0.15
|
2.98 Units on a scale
Standard Error 0.21
|
|
Patient Attitude Towards Use of Contraceptive Options
Patch
|
5.22 Units on a scale
Standard Error 0.20
|
5.4 Units on a scale
Standard Error 0.19
|
|
Patient Attitude Towards Use of Contraceptive Options
Ring
|
5.07 Units on a scale
Standard Error 0.18
|
5.49 Units on a scale
Standard Error 0.26
|
|
Patient Attitude Towards Use of Contraceptive Options
Shot
|
5.05 Units on a scale
Standard Error 0.18
|
5.35 Units on a scale
Standard Error 0.19
|
|
Patient Attitude Towards Use of Contraceptive Options
Hormonal IUD
|
6.61 Units on a scale
Standard Error .23
|
6.24 Units on a scale
Standard Error .18
|
|
Patient Attitude Towards Use of Contraceptive Options
Non-hormonal IUD
|
6.3 Units on a scale
Standard Error 0.21
|
6.29 Units on a scale
Standard Error 0.17
|
|
Patient Attitude Towards Use of Contraceptive Options
Implant
|
5.79 Units on a scale
Standard Error 0.16
|
6.06 Units on a scale
Standard Error 0.20
|
|
Patient Attitude Towards Use of Contraceptive Options
Condoms
|
6.33 Units on a scale
Standard Error 0.16
|
6.87 Units on a scale
Standard Error 0.15
|
|
Patient Attitude Towards Use of Contraceptive Options
Female sterilization
|
4.44 Units on a scale
Standard Error 0.27
|
5.59 Units on a scale
Standard Error 0.24
|
|
Patient Attitude Towards Use of Contraceptive Options
Male sterilization
|
4.98 Units on a scale
Standard Error 0.25
|
6.08 Units on a scale
Standard Error 0.28
|
SECONDARY outcome
Timeframe: Baseline (pre- and post-survey)Population: Only calculated for those patients who reported not having heard of method in pre-survey, and then completed post-survey. All other patients missing for this item and excluded from analysis.
Percentage of patients who reported having heard about a method in the post-survey, but not the pre-survey.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Newly Heard About Methods During Visit
Newly heard of implant · Missing
|
294 Participants
|
261 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of patch · Yes
|
39 Participants
|
38 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of patch · No
|
11 Participants
|
19 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of patch · Missing
|
354 Participants
|
288 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of ring · Yes
|
61 Participants
|
41 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of ring · No
|
24 Participants
|
23 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of ring · Missing
|
319 Participants
|
281 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of male sterilization · Yes
|
53 Participants
|
35 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of male sterilization · No
|
30 Participants
|
24 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of male sterilization · Missing
|
321 Participants
|
286 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of female sterilization · Yes
|
59 Participants
|
44 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of hormonal IUD · Yes
|
79 Participants
|
46 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of hormonal IUD · No
|
21 Participants
|
18 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of hormonal IUD · Missing
|
304 Participants
|
281 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of non-hormonal IUD · Yes
|
104 Participants
|
84 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of non-hormonal IUD · No
|
23 Participants
|
31 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of non-hormonal IUD · Missing
|
277 Participants
|
230 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of implant · Yes
|
80 Participants
|
58 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of implant · No
|
30 Participants
|
26 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of female sterilization · No
|
27 Participants
|
26 Participants
|
|
Newly Heard About Methods During Visit
Newly heard of female sterilization · Missing
|
318 Participants
|
275 Participants
|
SECONDARY outcome
Timeframe: Baseline (post-visit survey)Population: Observed in patients only. Only calculated among those participants who reported ever having had a family planning visit. All others missing.
Patient report on 5-point Likert scale question asking patient to compare this visit to last family planning visit (1=Today was much worse; 5=today was much better). Analyzed dichotomously as top score of 5 versus \<5.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Patient Rating of Visit as "Much Better" Than Previous Family Planning Visit
Much better
|
142 Participants
|
104 Participants
|
|
Patient Rating of Visit as "Much Better" Than Previous Family Planning Visit
Not much better
|
144 Participants
|
140 Participants
|
|
Patient Rating of Visit as "Much Better" Than Previous Family Planning Visit
Missing
|
118 Participants
|
101 Participants
|
SECONDARY outcome
Timeframe: Baseline visitPopulation: Observed in patients only
Total amount of time a patient spends in a clinic for a family planning visit, from check-in to check-out.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Total Clinic Visit Time
|
98.40 minutes
Standard Deviation 1.75
|
86.94 minutes
Standard Deviation 1.71
|
SECONDARY outcome
Timeframe: Baseline visitPopulation: Observed in patients
Total amount of time spent with the provider that is providing contraceptive counseling.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Time Spent With Contraceptive Counseling Provider
|
44.0 minutes
Standard Deviation 1.21
|
44.4 minutes
Standard Deviation 1.29
|
SECONDARY outcome
Timeframe: Change between baseline and end of study (up to 24 months post-enrollment). In multivariate analysis, follow-up score analyzed controlling for site and score at baseline (Analyses 1-3).Population: Observed in providers only
Provider participants were asked to respond to the Maslach Burnout Inventory on workplace burnout among human services workers. The scale includes 22 items with response options on a Likert scale of 0-6. Individual scores were calculated at both baseline and follow-up for three subscales: emotional exhaustion (Range: 0-54, with higher score representing higher emotional exhaustion), depersonalization (Range: 0-30, with a higher score representing higher depersonalization), and personal accomplishment (Range: 0-48, with a higher score representing more personal accomplishment in the workplace).
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=15 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=13 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Maslach Burnout Inventory
Change in emotional exhaustion
|
-2.27 Units on a scale
Standard Deviation 9.22
|
1.07 Units on a scale
Standard Deviation 9.38
|
|
Maslach Burnout Inventory
Change in depersonalization
|
-0.87 Units on a scale
Standard Deviation 4.10
|
0.46 Units on a scale
Standard Deviation 4.24
|
|
Maslach Burnout Inventory
Change in personal accomplishment
|
-0.80 Units on a scale
Standard Deviation 3.99
|
2.38 Units on a scale
Standard Deviation 5.30
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline (post-visit survey)Population: Observed in patients only
Patient report of whether or not patient chose highly effective method at baseline. Highly effective methods include implants, IUDs, and male and female sterilization.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Choice of a Highly Effective Method of Contraception at Baseline
Did not choose highly effective method
|
249 Participants
|
221 Participants
|
|
Choice of a Highly Effective Method of Contraception at Baseline
Missing
|
2 Participants
|
4 Participants
|
|
Choice of a Highly Effective Method of Contraception at Baseline
Chose highly effective method
|
153 Participants
|
120 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 and 7 months post-enrollmentPopulation: Observed in patients only
Whether patient is using a highly effective contraceptive method at 4 and 7 month follow-up survey. Highly effective methods include implant, IUDs, and male and female sterilization.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Use of a Highly Effective Method of Contraception at 4 and 7 Months Follow-up.
At 4 months · Yes
|
264 Participants
|
230 Participants
|
|
Use of a Highly Effective Method of Contraception at 4 and 7 Months Follow-up.
At 4 months · No
|
94 Participants
|
76 Participants
|
|
Use of a Highly Effective Method of Contraception at 4 and 7 Months Follow-up.
At 4 months · Missing
|
46 Participants
|
39 Participants
|
|
Use of a Highly Effective Method of Contraception at 4 and 7 Months Follow-up.
At 7 months · Yes
|
258 Participants
|
201 Participants
|
|
Use of a Highly Effective Method of Contraception at 4 and 7 Months Follow-up.
At 7 months · No
|
99 Participants
|
90 Participants
|
|
Use of a Highly Effective Method of Contraception at 4 and 7 Months Follow-up.
At 7 months · Missing
|
47 Participants
|
54 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 and 7 months post-enrollmentPatient report of whether or not patient is using a highly or moderately effective contraceptive method at 4 and 7 month follow-up survey. As defined by the Centers for Disease Control, moderately effective methods include injectables, pills, patch, vaginal ring, and diaphragm; typical failure rates range from 6-12%. Highly effective methods include implants, IUDs, and male and female sterilization; failure rates are less than 1%.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Use of Any Moderately or Highly Effective Method of Contraception at 4 and 7 Months Follow-up
At 4 months post-enrollment · Missing
|
46 Participants
|
39 Participants
|
|
Use of Any Moderately or Highly Effective Method of Contraception at 4 and 7 Months Follow-up
At 7 months post-enrollment · Yes
|
258 Participants
|
201 Participants
|
|
Use of Any Moderately or Highly Effective Method of Contraception at 4 and 7 Months Follow-up
At 7 months post-enrollment · No
|
99 Participants
|
90 Participants
|
|
Use of Any Moderately or Highly Effective Method of Contraception at 4 and 7 Months Follow-up
At 7 months post-enrollment · Missing
|
47 Participants
|
54 Participants
|
|
Use of Any Moderately or Highly Effective Method of Contraception at 4 and 7 Months Follow-up
At 4 months post-enrollment · Yes
|
264 Participants
|
230 Participants
|
|
Use of Any Moderately or Highly Effective Method of Contraception at 4 and 7 Months Follow-up
At 4 months post-enrollment · No
|
94 Participants
|
76 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 months and 7 months from enrollmentPopulation: Observed in patients only
Incidence of unplanned pregnancy among study participants, as determined by responses of patients who experienced a pregnancy to the 6-item London Measure of Unplanned Pregnancy. The London Measure includes items on attitude towards an experienced pregnancy and behaviors before pregnancy to determine the intendedness of pregnancy. The score range of the London Measure is 0-12, with a score of \<10 indicating unplanned pregnancy and a score of 10 or higher indicating planned pregnancy. We report the percentage of patients who report a pregnancy and report a score of \<10 on the London Measure.
Outcome measures
| Measure |
Contraceptive Decision Support Tool
n=404 Participants
Patients whose contraceptive counseling visits are scheduled with providers randomized to this arm will use the intervention immediately before their visit and bring the generated printout to their visit. Providers randomized to this arm will be free to integrate the tool and printout into their contraceptive counseling however they see fit.
Contraceptive Decision Support Tool: The decision support tool:
* Provides an educational session about different aspects of contraception
* Elicits patient preferences about different aspects of contraception
* Identifies potential contraindications to certain contraceptive methods
* Allows the patient to view details about and compare available contraceptive methods
* Suggests methods most appropriate based on the patient's preferences
* Collects questions the patient may have for her provider
* Generates a printout the patient can bring to her contraceptive counseling visit
|
Usual Care (Control)
n=345 Participants
Patients in this arm will receive usual family planning care.
|
|---|---|---|
|
Unplanned Pregnancy
At 4 months post-enrollment · Yes
|
11 Participants
|
8 Participants
|
|
Unplanned Pregnancy
At 4 months post-enrollment · No
|
350 Participants
|
300 Participants
|
|
Unplanned Pregnancy
At 4 months post-enrollment · Missing
|
43 Participants
|
37 Participants
|
|
Unplanned Pregnancy
At 7 months post-enrollment · Yes
|
24 Participants
|
11 Participants
|
|
Unplanned Pregnancy
At 7 months post-enrollment · No
|
336 Participants
|
280 Participants
|
|
Unplanned Pregnancy
At 7 months post-enrollment · Missing
|
44 Participants
|
54 Participants
|
Adverse Events
Contraceptive Decision Support Tool Patients
Usual Care (Control) Patients
Contraceptive Decision Support Tool Providers
Usual Care (Control) Providers
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Christine Dehlendorf, Principal Investigator
University of California, San Francisco
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place